Neutrophil Function in Chronic Liver Disease

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1981 Jul 1

PMID 7030541

Citations 15

Authors

A C Campbell

M W Dronfield

P J Toghill

W G Reeves

Affiliations

Soon will be listed here.

Abstract

Neutrophil locomotion, phagocytosis and killing of Candida albicans, and plasma opsonization of brewer's yeast were studied in 44 out-patients with chronic liver disease. There were four diagnostic groups: alcoholic liver disease (ALD), chronic active hepatitis (CAH), primary biliary cirrhosis (PBC) and cryptogenic cirrhosis (CC). Results were compared with a control group of patients with non-malignant disorders of the upper alimentary tract. Neutrophil locomotion induced by zymosan-activated autologous plasma was significantly depressed in patients with ALD and, to a lesser extent, in cryptogenic cirrhosis. With plasma from healthy donors, the patients' neutrophils showed normal locomotion. Plasma from patients with CAH gave slightly but significantly reduced phagocytosis of both Candida albicans and brewer's yeast, but the patients' cells had normal phagocytic and killing activity in the presence of normal plasma. Thus, no intrinsic abnormality in neutrophil function was found in these patients, but plasma defects, which differed in cirrhoses of different underlying aetiology, led to impaired neutrophil locomotion or phagocytosis. No correlations were found between these plasma defects and circulating levels of C3, C4, immune complexes or IgA.

Citing Articles

The Impact of Liver Failure on the Immune System.

Dabrowska A, Wilczynski B, Mastalerz J, Kucharczyk J, Kulbacka J, Szewczyk A Int J Mol Sci. 2024; 25(17).

PMID: 39273468 PMC: 11395474. DOI: 10.3390/ijms25179522.

Circulating neutrophil anti-pathogen dysfunction in cirrhosis.

Balazs I, Stadlbauer V JHEP Rep. 2023; 5(11):100871.

PMID: 37822786 PMC: 10562928. DOI: 10.1016/j.jhepr.2023.100871.

Abnormal Innate Immunity in Acute-on-Chronic Liver Failure: Immunotargets for Therapeutics.

Khanam A, Kottilil S Front Immunol. 2020; 11:2013.

PMID: 33117329 PMC: 7578249. DOI: 10.3389/fimmu.2020.02013.

Therapeutic Targeting of Neutrophil Granulocytes in Inflammatory Liver Disease.

Bartneck M, Wang J Front Immunol. 2019; 10:2257.

PMID: 31616430 PMC: 6764082. DOI: 10.3389/fimmu.2019.02257.

IL-4 Receptor Alpha Signaling through Macrophages Differentially Regulates Liver Fibrosis Progression and Reversal.

Weng S, Wang X, Vijayan S, Tang Y, Kim Y, Padberg K EBioMedicine. 2018; 29:92-103.

PMID: 29463471 PMC: 5925448. DOI: 10.1016/j.ebiom.2018.01.028.

References

UWAYDAH M, WEINBERG A . Bacterial endocarditis--a changing pattern. N Engl J Med. 1965; 273(23):1231-5. DOI: 10.1056/NEJM196512022732301. View

RUTENBURG A, Sonnenblick E, KOVEN I, SCHWEINBURG F, Fine J . Comparative response of normal and cirrhotic rats to intravenously injected bacteria. Proc Soc Exp Biol Med. 1959; 101(2):279-81. DOI: 10.3181/00379727-101-24910. View

Weksler B, Hill M . Inhibition of leukocyte migration by a staphylococcal factor. J Bacteriol. 1969; 98(3):1030-5. PMC: 315291. DOI: 10.1128/jb.98.3.1030-1035.1969. View

DuPont H, SPINK W . Infections due to gram-negative organisms: an analysis of 860 patients with bacteremia at the University of Minnesota Medical Center, 1958-1966. Medicine (Baltimore). 1969; 48(4):307-32. DOI: 10.1097/00005792-196907000-00003. View

CONN H, Fessel J . Spontaneous bacterial peritonitis in cirrhosis: variations on a theme. Medicine (Baltimore). 1971; 50(3):161-97. DOI: 10.1097/00005792-197105000-00002. View

DeMeo A, Andersen B . Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med. 1972; 286(14):735-40. DOI: 10.1056/NEJM197204062861401. View

Pagaltsos A, Smith M, Eddleston A, Williams R . Total haemolytic complement after liver transplantation and in liver disease. Transplantation. 1972; 14(1):41-6. DOI: 10.1097/00007890-197207000-00006. View

Finlayson N, Krohn K, Fauconnet M, Anderson K . Significance of serum complement levels in chronic liver disease. Gastroenterology. 1972; 63(4):653-9. View

Zigmond S, Hirsch J . Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. J Exp Med. 1973; 137(2):387-410. PMC: 2139498. DOI: 10.1084/jem.137.2.387. View

10.

Thompson R, Carter R, Stokes R, Geddes A, Goodall J . Serum immunoglobulins, complement component levels and autoantibodies in liver disease. Clin Exp Immunol. 1973; 14(3):335-46. PMC: 1553834. View

11.

Kourilsky O, Leroy C, Peltier A . Complement and liver cell function in 53 patients with liver disease. Am J Med. 1973; 55(6):783-90. DOI: 10.1016/0002-9343(73)90259-3. View

12.

Maderazo E, Ward P, Quintiliani R . Defective regulation of chemotaxis in cirrhosis. J Lab Clin Med. 1975; 85(4):621-30. View

13.

Van Epps D, STRICKLAND R, Williams Jr R . Inhibitors of leukocyte chemotaxis in alcoholic liver disease. Am J Med. 1975; 59(2):200-7. DOI: 10.1016/0002-9343(75)90354-x. View

14.

Zubler R, LANGE G, Lambert P, MIESCHER P . Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976; 116(1):232-5. View

15.

Van Epps D, Williams Jr R . Suppression of leukocyte chemotaxis by human IgA myeloma components. J Exp Med. 1976; 144(5):1227-42. PMC: 2190463. DOI: 10.1084/jem.144.5.1227. View

16.

Yamamura M, Boler J, Valdimarsson H . Phagocytosis measured as inhibition of uridine uptake by Candida albicans. J Immunol Methods. 1977; 14(1):19-24. DOI: 10.1016/s0022-1759(97)90016-8. View

17.

Thomas H . The immune response in hepatic cirrhosis: animal and human studies. Proc R Soc Med. 1977; 70(8):521-5. PMC: 1543291. View

18.

Yamamura M, Valdimarsson H . A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway. Immunology. 1978; 34(4):689-94. PMC: 1457179. View

19.

Wyke R, Rajkovic I, Eddleston A, Williams R . Defective opsonisation and complement deficiency in serum from patients with fulminant hepatic failure. Gut. 1980; 21(8):643-9. PMC: 1419118. DOI: 10.1136/gut.21.8.643. View

20.

Kemp A, Cripps A, Brown S . Suppression of leucocyte chemokinesis and chemotaxis by human IgA. Clin Exp Immunol. 1980; 40(2):388-95. PMC: 1536983. View